Send to:

Choose Destination
See comment in PubMed Commons below
Nat Immunol. 2014 May;15(5):449-56. doi: 10.1038/ni.2863. Epub 2014 Mar 30.

The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Author information

  • 1Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • 21] Department of Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan. [2] Department of Biochemistry, Toho University School of Medicine, Tokyo, Japan.
  • 3Division of Immune Regulation, La Jolla Institute, La Jolla, California, USA.


The physiological functions of members of the tumor-necrosis factor (TNF) receptor (TNFR)-associated factor (TRAF) family in T cell immunity are not well understood. We found that in the presence of interleukin 6 (IL-6), naive TRAF5-deficient CD4(+) T cells showed an enhanced ability to differentiate into the TH17 subset of helper T cells. Accordingly, TH17 cell-associated experimental autoimmune encephalomyelitis (EAE) was greatly exaggerated in Traf5(-/-) mice. Although it is normally linked with TNFR signaling pathways, TRAF5 constitutively associated with a cytoplasmic region in the signal-transducing receptor gp130 that overlaps with the binding site for the transcription activator STAT3 and suppressed the recruitment and activation of STAT3 in response to IL-6. Our results identify TRAF5 as a negative regulator of the IL-6 receptor signaling pathway that limits the induction of proinflammatory CD4(+) T cells that require IL-6 for their development.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk